Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092620 · ClinicalTrials.gov registry record
Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 142
- Enrollment target
NCT05092620: Clinical Trial study, sponsored by University of Michigan.
NCT05092620 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 142 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05092620 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 142 participants
- Enrollment target
Study Summary
The Biorepository will guide the Diabetic Foot Consortium (DFC) activities for collection and storing biosamples and data from participants enrolled in other current and future DFC research studies.
Primary Outcome
Proportion of participants consenting to participation in the biorepository from among DFC studies, by study and overall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2024-04-17 |
Why NCT05092620 stopped before completion
NCT05092620 is an observational study that tracks outcomes without assigning an intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05092620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05092620 about?
NCT05092620 is a clinical study titled "Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials". The Biorepository will guide the Diabetic Foot Consortium (DFC) activities for collection and storing biosamples and data from participants enrolled in other current and future DFC research studies.
What is the current status of trial NCT05092620?
This trial is currently terminated. The enrollment target is 142 participants. The study started on 2021-05-01. Estimated completion is 2024-04-17.
Who is sponsoring clinical trial NCT05092620?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI